May 2026
1. LIU R, Martin TA, Jordan NJ, Ruge F, et al
   [Corrigendum] Epithelial protein lost in neoplasm?alpha (EPLIN?alpha) is a potential prognostic marker for the progression of epithelial ovarian cancer.
   Int J Oncol. 2026;68:61.
   

   >> Share

   
   April 2026
2. MUKINOVIC E, Federmann S, Messling L, Sekeres M, et al
   Overcoming acquired doxorubicin resistance of ovarian carcinoma cells by verapamil?mediated promotion of DNA damage?driven cytotoxicity.
   Int J Oncol. 2026;68:48.
   

   >> Share

   
   February 2026
3. WANG F, Xu X, Guan B, Li X, et al
   Regulation and reversal of paclitaxel resistance via the STAT1?mediated apoptotic pathway in ovarian cancer.
   Int J Oncol. 2026;68:19.
   

   >> Share

   
   August 2025
4. LIU R, Martin TA, Jordan NJ, Ruge F, et al
   [Corrigendum] Metastasis suppressor 1 expression in human ovarian cancer: The impact on cellular migration and metastasis.
   Int J Oncol. 2025;67:64.
   

   >> Share

   
   
5. KAUSAR MA, Alshammari KF, Alenazi F, Anwar S, et al
   RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review).
   Int J Oncol. 2025;67:65.
   

   >> Share

   
   December 2024
6. LIU Y, Xiao H, Zeng H, Xiang Y, et al
   Beyond tumor?associated macrophages involved in spheroid formation and dissemination: Novel insights for ovarian cancer therapy (Review).
   Int J Oncol. 2024;65:117.
   

   >> Share

   
   November 2024
7. TAN H, He Q, Gong G, Wang Y, et al
   [Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
   Int J Oncol. 2024;65:110.
   

   >> Share

   
   August 2024
8. XU S, Zhu C, Xu Q, An Z, et al
   ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo pathway.
   Int J Oncol. 2024;65:76.
   

   >> Share

   
   June 2024
9. FU M, Deng F, Chen J, Fu L, et al
   Current data and future perspectives on DNA methylation in ovarian cancer (Review).
   Int J Oncol. 2024;64:62.
   

   >> Share

   
   March 2024
10. GRUNT TW, Wagner R, Ries A, Berghoff AS, et al
    Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells.
    Int J Oncol. 2024;64:24.
    

    >> Share

    
    
11. GENG D, Zhou Y, Wang M
    Advances in the role of GPX3 in ovarian cancer (Review).
    Int J Oncol. 2024;64:31.
    

    >> Share

    
    January 2024
12. LIU Y, Yang Y, Wang X, Yin S, et al
    Function of microRNA?124 in the pathogenesis of cancer (Review).
    Int J Oncol. 2024;64:6.
    

    >> Share

    
    November 2023
13. DENG F, Fu M, Zhao C, Lei J, et al
    Calcium signals and potential therapy targets in ovarian cancer (Review).
    Int J Oncol. 2023;63:125.
    

    >> Share

    
    October 2023
14. YUAN J, Guan W, Li X, Wang F, et al
    RBM15‑mediating MDR1 mRNA m(6)A methylation regulated by the TGF‑beta signaling pathway in paclitaxel‑resistant ovarian cancer.
    Int J Oncol. 2023;63:112.
    

    >> Share

    
    May 2023
15. CHEN Q, Shen S, Lv N, Tong J, et al
    Role of microRNAs in glycolysis in gynecological tumors (Review).
    Int J Oncol. 2023;62:63.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share